Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 02, 12:52
Statera BioPharma Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | -0.8015M |
| June 30, 2022 | -0.1685M |
| March 31, 2022 | -3.768M |
| December 31, 2021 | -7.456M |
| September 30, 2021 | -15.28M |
| Date | Value |
|---|---|
| June 30, 2021 | -3.040M |
| March 31, 2021 | -2.597M |
| December 31, 2020 | |
| September 30, 2020 | |
| March 31, 2020 | -0.0016M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-15.28M
Minimum
Sep 2021
-0.0016M
Maximum
Mar 2020
-4.140M
Average
-2.818M
Median
Free Cash Flow (Quarterly) Benchmarks
| Cantabio Pharmaceuticals Inc | -- |
| Q BioMed Inc | -0.1382M |
| NVN Liquidation Inc | -- |
| Affymax Inc | -- |
| Scopus BioPharma Inc | -1.009M |